MLICM
AKRX

Metropolitan Life Insurance Company (MetLife)’s Akorn Inc AKRX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AKRX Stock Details AKRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30,760
Closed -$117K – 2590
2019
Q3 		$117K Hold
30,760
– – ﹤0.01% 2214
2019
Q2 		$158K Hold
30,760
– – ﹤0.01% 2039
2019
Q1 		$108K Hold
30,760
– – ﹤0.01% 2283
2018
Q4 		$104K Sell
30,760
-24,555
-44% -$146K ﹤0.01% 2242
2018
Q3 		$718K Sell
55,315
-11
-0% -$181 0.01% 1115
2018
Q2 		$918K Buy
55,326
+24,449
+79% +$375K 0.01% 966
2018
Q1 		$578K Buy
30,877
+233
+0.8% +$6.32K 0.01% 1179
2017
Q4 		$988K Sell
30,644
-61,237
-67% -$2.01M 0.01% 894
2017
Q3 		$3.05M Buy
91,881
+5,985
+7% +$199K 0.02% 814
2017
Q2 		$2.88M Buy
85,896
+1,464
+2% +$47.7K 0.02% 843
2017
Q1 		$2.03M Sell
84,432
-733
-0.9% -$16K 0.01% 947
2016
Q4 		$1.86M Sell
85,165
-1,017
-1% -$23.4K 0.01% 1001
2016
Q3 		$2.35M Buy
86,182
+3,818
+5% +$113K 0.02% 898
2016
Q2 		$2.35M Buy
82,364
+6,226
+8% +$173K 0.02% 880
2016
Q1 		$1.79M Buy
76,138
+2,054
+3% +$54K 0.01% 931
2015
Q4 		$2.76M Buy
74,084
+447
+0.6% +$14K 0.02% 767
2015
Q3 		$2.1M Buy
73,637
+364
+0.5% +$15K 0.02% 893
2015
Q2 		$3.2M Sell
73,273
-37,321
-34% -$1.73M 0.02% 768
2015
Q1 		$5.25M Buy
110,594
+63,340
+134% +$2.88M 0.04% 505
2014
Q4 		$1.71M Hold
47,254
– – 0.01% 1028
2014
Q3 		$1.71M Sell
47,254
-1,910
-4% -$68.4K 0.01% 1006
2014
Q2 		$1.64M Hold
49,164
– – 0.01% 1085
2014
Q1 		$1.08M Hold
49,164
– – 0.01% 1287
2013
Q4 		$1.21M Buy
49,164
+4,275
+10% +$96.6K 0.01% 1221
2013
Q3 		$883K Hold
44,889
– – 0.01% 1351
2013
Q2 		$607K Buy
+44,889
New +$635K ﹤0.01% 1571

Other funds holding AKRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AKRX Position: Q4 2019 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Akorn Inc (AKRX) in Q4 2019, closing a stake of 30,760 shares — an estimated $117K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AKRX in Q2 2013 and held it in 26 quarters. The position peaked at $5.25M in Q1 2015. 143 funds tracked by Wall St. Rank hold AKRX as of Q4 2019.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Akorn Inc position as of Q4 2019 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 30,760 Akorn Inc shares in Q4 2019, an estimated $117K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Akorn Inc in Q2 2013 and held it in 26 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Akorn Inc position peaked at $5.25M in Q1 2015.
  • 143 funds tracked by Wall St. Rank held Akorn Inc as of Q4 2019.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2019, filed 14 Feb 2020.